JIM
EW icon

Jupiter Investment Management’s Edwards Lifesciences EW Stock Holding History

Jupiter Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-769,653
Closed -$47.4M – 450
2019
Q2 		$47.4M Buy
+769,653
New +$46.5M 0.48% 76

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Jupiter Investment Management's EW Position: Q2 2020 in Review

Jupiter Investment Management reduced its Edwards Lifesciences (EW) stake by 15% in Q2 2020, selling an estimated $13.3M and leaving 1,055,323 shares worth $72.9M. The position accounts for 1.16% of the portfolio, ranked #19.

Jupiter Investment Management first reported a position in EW in Q3 2013 and has held it in 26 quarters since. The position peaked at $183M in Q3 2018. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Jupiter Investment Management held 1,055,323 shares of Edwards Lifesciences worth $72.9M as of Q2 2020.
  • Jupiter Investment Management sold 187,700 Edwards Lifesciences shares in Q2 2020, an estimated $13.3M.
  • Edwards Lifesciences made up 1.16% of Jupiter Investment Management's portfolio in Q2 2020, its #19 holding.
  • Jupiter Investment Management first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 26 quarters since.
  • Jupiter Investment Management's Edwards Lifesciences position peaked at $183M in Q3 2018.
  • 1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.